Amid a changing and challenging time for academic medicine, Weill Cornell Medicine is poised to thrive in the coming years, with a planned expansion of its clinical enterprise serving as an engine for overall institutional growth, Dean Robert Harrington conveyed Dec. 16 during his biannual State of Weill Cornell Medicine address.
Weill Cornell, like many academic research institutions nationwide, has navigated financial uncertainty stemming from rapidly changing federal research support. But these challenges also revealed an opportunity to evaluate Weill Cornell’s core strengths—culminating in a plan to create the “academic medical center of the future,” said Dr. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University.
“I know this has been a tough year, but I’m also optimistic about the future,” he said. “And I’m especially optimistic because of the quality of the people that we have working across every domain: clinical, research and education.”
